A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us.

Publication of Interim Results and Presentation at Recent Industry Event Demonstrate Clinical Benefit Associated with Use of ...

University of Auckland researchers report that an 8-week, twice-weekly LSD microdosing regimen for major depressive disorder ...

Pegozafermin is a long-acting glycopegylated (pegylated with the use of site-specific glycosyltransferases) fibroblast growth factor 21 (FGF21) analogue in development for the treatment of ...

Black and Hispanic individuals with obesity appear underrepresented in GLP-1 weight loss trials, compared with the overall ...

Chao-Yi Wu, PhD, OT, from the Department of Neurology and Edmarie Guzmán-Vélez, PhD, of the Department of Psychiatry at Mass General Brigham, are the lead and senior authors of a paper published in ...

Penumbra, Inc. (NYSE: PEN) announced additional results of the ground-breaking STORM-PE randomized controlled trial (RCT), ...

Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O6-Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET) The median time post-HCT was ...

New research reveals that tirzepatide and semaglutide both offer strong, early heart-protective effects. A major new ...

Nearing its 14th anniversary, Notre Dame’s Wilson Sheehan Lab for Economic Opportunity continues evaluating the impact of ...